Sun Hao, Duan Jun, Li Fengsheng
Department of Orthopedics, Guangzhou Red Cross Hospital, The Fourth Affiliated Hospital of JiNan University, 396 Tong Fu Zhong Road, Guangzhou, 510220, Guangdong, China.
Eur J Orthop Surg Traumatol. 2016 Apr;26(3):283-91. doi: 10.1007/s00590-016-1739-1. Epub 2016 Jan 21.
Open reduction and internal fixation (ORIF) and radial head arthroplasty (RHA) are the most common operative treatments in patients with radial head fractures. The purpose of this study was to determine the efficacy of RHA and ORIF treatments in patients with radial head fractures (modified Mason type III and IV).
We conducted a computerized search of five electronic databases from their inception to July 2015. All clinical trials comparing ORIF versus RHA treatment in patients with radial head fractures were included. We evaluated the primary outcomes included elbow functional evaluation criteria by Broberg and Morrey, elbow score (Broberg and Morrey), Mayo Elbow Performance Score (MEPS) and QuickDASH score. Secondary outcomes included Visual Analog Scale (VAS), range of motion, operation time and complications. The "assessing risk of bias" table was applied to assess the risk of bias of the included studies.
Eight studies were included in this meta-analysis, which consisted of 138 cases of ORIF and 181 RHA. Methodological quality of the studies was moderate to low. RHA afforded significantly higher satisfaction rate, better elbow score (Broberg and Morrey) and MEPS, shorter operation time, lower incidence of bone nonunion or absorption and internal fixation failure when compared to ORIF. There were no significantly differences in QuickDASH score and other complications.
RHA has better outcome in patients with radial head fractures (modified Mason type III and IV) than ORIF with medium-short-term follow-up period, but longer-term studies will be required to ascertain whether the apparent benefits of RHA were offset by late complications.
Therapeutic decision analysis; a meta-analysis, Level III.
切开复位内固定术(ORIF)和桡骨头置换术(RHA)是桡骨头骨折患者最常用的手术治疗方法。本研究旨在确定RHA和ORIF治疗桡骨头骨折(改良Mason III型和IV型)患者的疗效。
我们对五个电子数据库从建库至2015年7月进行了计算机检索。纳入所有比较ORIF与RHA治疗桡骨头骨折患者的临床试验。我们评估的主要结局包括Broberg和Morrey的肘关节功能评估标准、肘关节评分(Broberg和Morrey)、Mayo肘关节功能评分(MEPS)和QuickDASH评分。次要结局包括视觉模拟评分(VAS)、活动范围、手术时间和并发症。应用“评估偏倚风险”表评估纳入研究的偏倚风险。
本荟萃分析纳入八项研究,其中切开复位内固定术138例,桡骨头置换术181例。研究的方法学质量为中到低。与切开复位内固定术相比,桡骨头置换术的满意率显著更高,肘关节评分(Broberg和Morrey)和Mayo肘关节功能评分更好,手术时间更短,骨不连或吸收及内固定失败的发生率更低。QuickDASH评分和其他并发症无显著差异。
在中期至短期随访中,桡骨头骨折(改良Mason III型和IV型)患者接受桡骨头置换术比切开复位内固定术有更好的疗效,但需要长期研究来确定桡骨头置换术的明显益处是否会被晚期并发症抵消。
治疗决策分析;荟萃分析,III级。